For research teamsFind studies
Study directory

Mental health studies with practical context.

Public study records, presented in a clearer and more patient-friendly format for mental health research discovery.

Back to overview
724studies shown
Showing 76-100 of 724
RecruitingNCT06301347

Learning Through Play Plus for Psychosis

This study is recruiting. It focuses on schizophrenia and currently lists participation information in Pakistan.

SchizophreniaOtherOver 18 Years
Countries
Pakistan
Sponsor
Pakistan Institute of Living and Learning
Condition
Schizophrenia
View study
RecruitingNCT06911931

Visual Perception in Schizophrenia

This study is recruiting. It focuses on schizophrenia and currently lists participation information in the United States.

SchizophreniaOtherFrom 18 Years to 65 Years
Countries
United States
Sponsor
University of Rochester
Condition
Schizophrenia
View study
RecruitingNCT06687694

Immune Mechanisms of Antipsychotic Treatment Response

This study is recruiting. It focuses on schizophrenia and currently lists participation information in the United Kingdom.

SchizophreniaOtherFrom 18 Years to 65 Years
Countries
United Kingdom
Sponsor
King's College London
Condition
Schizophrenia
View study
RecruitingNCT07424404

A Study to Evaluate the Long-term Safety and Tolerability of KarXT and KarX-EC for the Treatment of Schizophrenia and Autism-Related Irritability in Adolescents, Respectively

This study is recruiting. It focuses on schizophrenia and currently lists participation information in Canada, France, Germany, Hungary, Japan, Poland, Romania, Spain, and the United States.

SchizophreniaOtherFrom 5 Years to 17 Years
Countries
Canada, France, Germany, Hungary, Japan, Poland, Romania, Spain, United States
Sponsor
Karuna Therapeutics, Inc., a Bristol Myers Squibb company
Condition
Schizophrenia
View study
RecruitingNCT05142735

Effects of NAC on Symptoms of CHR Patients

This study is recruiting. It focuses on schizophrenia and currently lists participation information in Canada.

SchizophreniaOtherFrom 16 Years to 35 Years
Countries
Canada
Sponsor
Centre for Addiction and Mental Health
Condition
Schizophrenia
View study
RecruitingNCT07410507

A Study of Brenipatide in Adult Participants With Schizophrenia

This study is recruiting. It focuses on schizophrenia and currently lists participation information in Argentina, Brazil, China, India, Japan, Taiwan, and the United States.

SchizophreniaOtherFrom 18 Years to 55 Years
Countries
Argentina, Brazil, China, India, Japan, Taiwan, United States
Sponsor
Eli Lilly and Company
Condition
Schizophrenia
View study
RecruitingNCT04745143

Monotherapy of an NMDA Enhancer for Schizophrenia

This study is recruiting. It focuses on schizophrenia and currently lists participation information in Taiwan.

SchizophreniaOtherFrom 18 Years to 65 Years
Countries
Taiwan
Sponsor
China Medical University Hospital
Condition
Schizophrenia
View study
RecruitingNCT06585787

A Study to Evaluate KarXT as a Treatment for Psychosis Associated With Alzheimer's Disease (ADEPT-4)

This study is recruiting. It focuses on schizophrenia and currently lists participation information in Argentina, Belgium, Brazil, Bulgaria, China, Croatia, France, Germany, Greece, Hungary, India, Israel, Italy, Japan, Poland, Portugal, the United States, Romania, Serbia, Slovakia, South Korea, Spain, Turkey, and Ukraine.

SchizophreniaOtherFrom 55 Years to 90 Years
Countries
Argentina, Belgium, Brazil, Bulgaria, China, Croatia, France, Germany, Greece, Hungary, India, Israel, Italy, Japan, Poland, Portugal, United States, Romania, Serbia, Slovakia, South Korea, Spain, Turkey, Ukraine
Sponsor
Karuna Therapeutics, Inc., a Bristol Myers Squibb company
Condition
Schizophrenia
View study